These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33979683)

  • 41. EZH2 in normal hematopoiesis and hematological malignancies.
    Herviou L; Cavalli G; Cartron G; Klein B; Moreaux J
    Oncotarget; 2016 Jan; 7(3):2284-96. PubMed ID: 26497210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of miR-29 family members in malignant hematopoiesis.
    Kollinerova S; Vassanelli S; Modriansky M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Dec; 158(4):489-501. PubMed ID: 24993745
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ETV6 and ETV7: Siblings in hematopoiesis and its disruption in disease.
    Rasighaemi P; Ward AC
    Crit Rev Oncol Hematol; 2017 Aug; 116():106-115. PubMed ID: 28693791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Age-related clonal hematopoiesis: implications for hematopoietic stem cell transplantation.
    Abelson S; Wang JCY
    Curr Opin Hematol; 2018 Nov; 25(6):441-445. PubMed ID: 30124476
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concise Review: Age-Related Clonal Hematopoiesis: Stem Cells Tempting the Devil.
    Busque L; Buscarlet M; Mollica L; Levine RL
    Stem Cells; 2018 Sep; 36(9):1287-1294. PubMed ID: 29883022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetics in Hematological Malignancies.
    Cruz-Rodriguez N; Combita AL; Zabaleta J
    Methods Mol Biol; 2018; 1856():87-101. PubMed ID: 30178247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proteomics in hematologic malignancies.
    Caron M; Joubert-Caron R
    Expert Rev Proteomics; 2005 Aug; 2(4):567-76. PubMed ID: 16097889
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Single-cell proteomic analysis.
    Pham T; Tyagi A; Wang YS; Guo J
    WIREs Mech Dis; 2021 Jan; 13(1):e1503. PubMed ID: 32748522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-1β as emerging therapeutic target in hematological malignancies and potentially in their complications.
    Arranz L; Arriero MDM; Villatoro A
    Blood Rev; 2017 Sep; 31(5):306-317. PubMed ID: 28495184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clonal hematopoiesis.
    Jan M; Ebert BL; Jaiswal S
    Semin Hematol; 2017 Jan; 54(1):43-50. PubMed ID: 28088988
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polycomb complexes PRC1 and their function in hematopoiesis.
    Vidal M; Starowicz K
    Exp Hematol; 2017 Apr; 48():12-31. PubMed ID: 28087428
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.
    Steensma DP; Bejar R; Jaiswal S; Lindsley RC; Sekeres MA; Hasserjian RP; Ebert BL
    Blood; 2015 Jul; 126(1):9-16. PubMed ID: 25931582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The regulation of normal and neoplastic hematopoiesis is dependent on microenvironmental cells.
    Kaushansky K; Zhan H
    Adv Biol Regul; 2018 Aug; 69():11-15. PubMed ID: 29970351
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genomic approaches to the pathogenesis of hematologic malignancy.
    Golub TR
    Curr Opin Hematol; 2001 Jul; 8(4):252-61. PubMed ID: 11561164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clonal hematopoiesis as a model for premalignant changes during aging.
    Steensma DP; Ebert BL
    Exp Hematol; 2020 Mar; 83():48-56. PubMed ID: 31838005
    [TBL] [Abstract][Full Text] [Related]  

  • 56. From the (Epi)Genome to Metabolism and Vice Versa; Examples from Hematologic Malignancy.
    Karagianni P; Giannouli S; Voulgarelis M
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204821
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes.
    Coombs CC; Zehir A; Devlin SM; Kishtagari A; Syed A; Jonsson P; Hyman DM; Solit DB; Robson ME; Baselga J; Arcila ME; Ladanyi M; Tallman MS; Levine RL; Berger MF
    Cell Stem Cell; 2017 Sep; 21(3):374-382.e4. PubMed ID: 28803919
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Wnt/beta-catenin signal pathway and malignant hematological disease -- review].
    Wang YX; Zhang JH; Gu ZW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):234-7. PubMed ID: 19236787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Applications of single-cell sequencing in cancer research: progress and perspectives.
    Lei Y; Tang R; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
    J Hematol Oncol; 2021 Jun; 14(1):91. PubMed ID: 34108022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insights into clonal hematopoiesis and its relation to cancer risk.
    Mitchell SR; Gopakumar J; Jaiswal S
    Curr Opin Genet Dev; 2021 Feb; 66():63-69. PubMed ID: 33422951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.